Global Next-Generation Sequencing (NGS) Market 2018-2024
Global Next-generation sequencing Market – Drivers, Opportunities, Trends, and Forecasts: 2018–2024
Overview: Next-generation sequencing (NGS) is the massively parallel sequencing technology that has revolutionized the biological sciences. With its ultra-high throughput, scalability, and speed, NGS enables researchers to perform a wide variety of applications and study biological systems at a level never before possible. Illumina, Pacific Biosciences of California, Thermo Fisher scientific and Oxford Nanopore technology offers next-generation sequencing instruments based on different technologies such as Reversible terminator sequencing, Sequencing by ligation, Single-molecule, real-time sequencing (SMRT), ion semiconductor sequencing technology and Nanopore sequencing technology respectively. Wide range of diagnostic applications, continuous technology advancements are making it more efficient and user-friendly, but the complications associated with data storage and lack of skilled professional are some of the factors which may hamper growth to an extent.
Market Analysis: The “Global Next-Generation Sequencing market” is estimated to witness a CAGR of 18.6% during the forecast period 2018–2024. The global market is analyzed based on five segments – Technology, Products, Application, End-users and regions.
Regional Analysis: The regions covered in the report are the North America, Europe, Asia Pacific, and Rest of the World (ROW). North America is the major shareholder in the global next-generation sequencing market, followed by Europe. Asia-Pacific region is expected to grow at high CAGR during the forecasted period due to increasing funding for healthcare research, growing patient pool, and increasing healthcare expenditure. The markets in emerging counties such as, India, China and Brazil are expected to grow at a rapid pace for next five years.
Technology Analysis: The next-generation sequencing market by technology is segmented into reversible terminator sequencing, ion semiconductor sequencing, sequencing by ligation, single molecule real-time sequencing, nanopore sequencing and others. Reversible terminator sequencing occupied a major market share in 2017 and is expected to remain same during the forecasted period.
Product Analysis: The market by product type is segmented into instruments, consumables and reagents and services. The services segment of the NGS market includes data analysis services and sequencing services. Among various application, consumables and reagents occupied the largest share in 2017, due to increased usage and need of consumables throughout the sample preparation, library construction, and various other pre-requisite steps of next-generation sequencing.
Application Analysis: The market by application is segmented into diagnostics, biomarker discovery, drug discovery, agriculture and animal research and others. Diagnostics includes prenatal testing, cancer diagnostics, genetic screening, pre-implantation, HLA typing and various other clinical diagnostics applications. The diagnostics application occupied a major share in 2017, due to increasing usage of next-generation sequencing for disease diagnosis.
End-Users Analysis: The market by end-users is segmented into academic and research institutes, hospitals and clinics, biotech and pharma companies and others. Among various end-users of the NGS market, academic and research institutes occupied a major share in 2017.
Key Players: Illumina, Inc., Thermo Fisher Scientific, Inc., Pacific Biosciences of California, Oxford Nanopore Technologies Limited, Beijing Genomics Institute, Agilent Technologies, Inc., Qiagen N.V., Eurofins Scientific, F. Hoffmann-La Roche, DNASTAR, Inc., Biomatters Limited and other predominate and niche players.
Competitive Analysis: Currently the next-generation sequencing market is consolidated with few key companies due to the involvement of complicated technologies and the requirement of high capital investment. Sequencing based test may soon be regarded as the gold standard in the field of molecular diagnostics. The increase in the applications of NGS has made many biotechnological firms and diagnostic laboratories to invest heavily in this field by launching new products or acquiring other smaller firms or by collaboration. For instance, in August 2017, US based Illumina and Telegraph Hill Partners launched Verogen, Inc. to drive adoption of NGS in the global forensic genomics Market. In February 2018, Twist Bioscience entered the NGS sample prep market with the launch of its first target enrichment products. In March 2017, MedGenome launched NGS based liquid biopsy blood test “Oncotrack” for the diagnosis of cancer in India.
Benefits: The report provides complete details about the usage and adoption rate of Next-generation Sequencing in various therapeutic verticals and regions. With that, key stakeholders can know about the major trends, drivers, investments, and vertical player’s initiatives. Moreover, the report provides details about the major challenges that are going to impact on the market growth. Additionally, the report gives the complete details about the key business opportunities to key stakeholders to expand their business and capture the revenue in the specific verticals to analyze before investing or expanding the business in this market.
Overview: Next-generation sequencing (NGS) is the massively parallel sequencing technology that has revolutionized the biological sciences. With its ultra-high throughput, scalability, and speed, NGS enables researchers to perform a wide variety of applications and study biological systems at a level never before possible. Illumina, Pacific Biosciences of California, Thermo Fisher scientific and Oxford Nanopore technology offers next-generation sequencing instruments based on different technologies such as Reversible terminator sequencing, Sequencing by ligation, Single-molecule, real-time sequencing (SMRT), ion semiconductor sequencing technology and Nanopore sequencing technology respectively. Wide range of diagnostic applications, continuous technology advancements are making it more efficient and user-friendly, but the complications associated with data storage and lack of skilled professional are some of the factors which may hamper growth to an extent.
Market Analysis: The “Global Next-Generation Sequencing market” is estimated to witness a CAGR of 18.6% during the forecast period 2018–2024. The global market is analyzed based on five segments – Technology, Products, Application, End-users and regions.
Regional Analysis: The regions covered in the report are the North America, Europe, Asia Pacific, and Rest of the World (ROW). North America is the major shareholder in the global next-generation sequencing market, followed by Europe. Asia-Pacific region is expected to grow at high CAGR during the forecasted period due to increasing funding for healthcare research, growing patient pool, and increasing healthcare expenditure. The markets in emerging counties such as, India, China and Brazil are expected to grow at a rapid pace for next five years.
Technology Analysis: The next-generation sequencing market by technology is segmented into reversible terminator sequencing, ion semiconductor sequencing, sequencing by ligation, single molecule real-time sequencing, nanopore sequencing and others. Reversible terminator sequencing occupied a major market share in 2017 and is expected to remain same during the forecasted period.
Product Analysis: The market by product type is segmented into instruments, consumables and reagents and services. The services segment of the NGS market includes data analysis services and sequencing services. Among various application, consumables and reagents occupied the largest share in 2017, due to increased usage and need of consumables throughout the sample preparation, library construction, and various other pre-requisite steps of next-generation sequencing.
Application Analysis: The market by application is segmented into diagnostics, biomarker discovery, drug discovery, agriculture and animal research and others. Diagnostics includes prenatal testing, cancer diagnostics, genetic screening, pre-implantation, HLA typing and various other clinical diagnostics applications. The diagnostics application occupied a major share in 2017, due to increasing usage of next-generation sequencing for disease diagnosis.
End-Users Analysis: The market by end-users is segmented into academic and research institutes, hospitals and clinics, biotech and pharma companies and others. Among various end-users of the NGS market, academic and research institutes occupied a major share in 2017.
Key Players: Illumina, Inc., Thermo Fisher Scientific, Inc., Pacific Biosciences of California, Oxford Nanopore Technologies Limited, Beijing Genomics Institute, Agilent Technologies, Inc., Qiagen N.V., Eurofins Scientific, F. Hoffmann-La Roche, DNASTAR, Inc., Biomatters Limited and other predominate and niche players.
Competitive Analysis: Currently the next-generation sequencing market is consolidated with few key companies due to the involvement of complicated technologies and the requirement of high capital investment. Sequencing based test may soon be regarded as the gold standard in the field of molecular diagnostics. The increase in the applications of NGS has made many biotechnological firms and diagnostic laboratories to invest heavily in this field by launching new products or acquiring other smaller firms or by collaboration. For instance, in August 2017, US based Illumina and Telegraph Hill Partners launched Verogen, Inc. to drive adoption of NGS in the global forensic genomics Market. In February 2018, Twist Bioscience entered the NGS sample prep market with the launch of its first target enrichment products. In March 2017, MedGenome launched NGS based liquid biopsy blood test “Oncotrack” for the diagnosis of cancer in India.
Benefits: The report provides complete details about the usage and adoption rate of Next-generation Sequencing in various therapeutic verticals and regions. With that, key stakeholders can know about the major trends, drivers, investments, and vertical player’s initiatives. Moreover, the report provides details about the major challenges that are going to impact on the market growth. Additionally, the report gives the complete details about the key business opportunities to key stakeholders to expand their business and capture the revenue in the specific verticals to analyze before investing or expanding the business in this market.
1 INDUSTRY OUTLOOK
1.1 Market Overview
1.2 Total addressable market
2 REPORT OUTLINE
2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions
3 MARKET SNAPSHOT
3.1 Market Definition – Infoholic Research
3.2 Advantages of next-generation sequencing
3.3 Segmented Addressable Market (SAM)
3.4 Trends of the next-generation sequencing market
3.5 Related Markets
3.5.1 Polymerase chain reaction (PCR)
3.5.2 In-situ Hybridization
3.5.3 Microarray
4 MARKET OUTLOOK
4.1 Market segmentation
4.2 PEST Analysis
4.3 Porter 5(Five) Forces
5 MARKET CHARACTERISTICS
5.1 DRO – Global Next-generation sequencing Market Dynamics
5.1.1 Drivers
5.1.1.1 Usage of sequencing in wide range of diagnostic application
5.1.1.2 High speed, accuracy and reduced sequencing cost
5.1.2 Opportunities
5.1.2.1 Emerging applications of next-generation sequencing
5.1.2.2 Evolution of personalized medicine
5.1.3 Restraints
5.1.3.1 Complications associated with NGS data storage
5.1.3.2 Lack of skilled professional
5.2 DRO – Impact Analysis
5.3 Key Stakeholders
6 TECHNOLOGY: MARKET SIZE & ANALYSIS
6.1 Overview
6.2 Reversible terminator sequencing
6.3 Ion semiconductor sequencing
6.4 Sequencing by ligation
6.5 Single molecule real-time (SMRT) sequencing
6.6 Nanopore sequencing
6.7 Others
7 PRODUCT: MARKET SIZE & ANALYSIS
7.1 Overview
7.2 Instruments
7.3 Consumables and reagents
7.4 Services
8 APPLICATIONS: MARKET SIZE & ANALYSIS
8.1 Overview
8.2 Diagnostics
8.3 Biomarker discovery
8.4 Drug discovery
8.5 Agriculture and animal research
8.6 Other application
9 END-USER: MARKET SIZE & ANALYSIS
9.1 Overview
9.2 Hospital and reference laboratories
9.3 Academic and research institutions
9.4 Biotech and pharma companies
9.5 Others
10 REGIONS: MARKET SIZE AND ANALYSIS
10.1 Overview
10.2 North America
10.3 Europe
10.4 Asia Pacific
10.5 Rest of the World
11 COMPETITIVE LANDSCAPE
11.1 Overview
12 VENDOR PROFILES
12.1 Illumina, Inc
12.1.1 Overview
12.1.2 Illumina, Inc.: Recent Developments
12.1.3 Business Units
12.1.4 Geographic Revenue
12.1.5 Business Focus
12.1.6 SWOT Analysis
12.1.7 Business Strategies
12.2 Thermo Fisher Scientific Inc
12.2.1 Overview
12.2.2 Thermo Fisher Scientific Inc.: Recent Developments
12.2.3 Business Units
12.2.4 Geographic Presence
12.2.5 Business Focus
12.2.6 SWOT Analysis
12.2.7 Business Strategies
12.3 Pacific Biosciences of California, Inc
12.3.1 Overview
12.3.2 Geographic Presence
12.3.3 Business Focus
12.3.4 SWOT Analysis
12.3.5 Business Strategies
12.4 Oxford Nanopore Technologies Ltd
12.4.1 Overview
12.4.2 Business Focus
12.4.3 SWOT Analysis
12.4.4 Business Strategies
12.5 Beijing Genomics Institute
12.5.1 Overview
12.5.2 Business Focus
12.5.3 SWOT Analysis
12.5.4 Business Strategies
13 COMPANIES TO WATCH FOR
13.1 DNASTAR, Inc.,
13.1.1 Overview
13.2 Agilent Technologies, Inc
13.2.1 Overview
13.3 Qiagen N.V
13.3.1 Overview
13.4 Eurofins Scientific
13.4.1 Overview
13.5 Biomatters Limited
13.5.1 Overview
13.6 F .Hoffmann-La Roche
13.6.1 Overview
Annexure
Acronyms
Table 1 GLOBAL NEXT-GENERATION SEQUENCING MARKET BY APPLICATION, 2017–2024 ($MILLION)
Table 2 GLOBAL NEXT-GENERATION SEQUENCING MARKET REVENUE BY REGIONS, 2017–2024 ($MILLION)
Table 3 OTHER PROMINENT VENDORS OF NEXT-GENERATION SEQUENCING MARKET
Table 4 ILLUMINA, INC.: OFFERINGS
Table 5 THERMO FISHER SCIENTIFIC INC.: PRODUCT OFFERINGS
Table 6 PACIFIC BIOSCIENCES OF CALIFORNIA, INC.: OFFERINGS
Table 7 PACIFIC BIOSCIENCES OF CALIFORNIA, INC: RECENT DEVELOPMENTS
Table 8 OXFORD NANOPORE TECHNOLOGIES LTD: OFFERINGS
Table 9 OXFORD NANOPORE TECHNOLOGIES LTD: RECENT DEVELOPMENTS
Table 10 BEIJING GENOMICS INSTITUTE: OFFERINGS
Table 11 BEIJING GENOMICS INSTITUTE: RECENT DEVELOPMENTS
Table 12 DNASTAR, INC.: SNAPSHOT
Table 13 DNASTAR, INC.: RECENT DEVELOPMENTS
Table 14 AGILENT TECHNOLOGIES, INC.: SNAPSHOT
Table 15 AGILENT TECHNOLOGIES, INC.: RECENT DEVELOPMENTS
Table 16 QIAGEN N.V.: SNAPSHOT
Table 17 QIAGEN N.V.: RECENT DEVELOPMENTS
Table 18 EUROFINS SCIENTIFIC: SNAPSHOT
Table 19 EUROFIN SCIENTIFIC: RECENT DEVELOPMENTS
Table 20 BIOMATTERS LIMITED: SNAPSHOT
Table 21 BIOMATTERS LTD: RECENT DEVELOPMENTS
Table 22 F .HOFFMANN-LA ROCHE: SNAPSHOT
Table 23 F .HOFFMANN-LA ROCHE: RECENT DEVELOPMENTS
1.1 Market Overview
1.2 Total addressable market
2 REPORT OUTLINE
2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions
3 MARKET SNAPSHOT
3.1 Market Definition – Infoholic Research
3.2 Advantages of next-generation sequencing
3.3 Segmented Addressable Market (SAM)
3.4 Trends of the next-generation sequencing market
3.5 Related Markets
3.5.1 Polymerase chain reaction (PCR)
3.5.2 In-situ Hybridization
3.5.3 Microarray
4 MARKET OUTLOOK
4.1 Market segmentation
4.2 PEST Analysis
4.3 Porter 5(Five) Forces
5 MARKET CHARACTERISTICS
5.1 DRO – Global Next-generation sequencing Market Dynamics
5.1.1 Drivers
5.1.1.1 Usage of sequencing in wide range of diagnostic application
5.1.1.2 High speed, accuracy and reduced sequencing cost
5.1.2 Opportunities
5.1.2.1 Emerging applications of next-generation sequencing
5.1.2.2 Evolution of personalized medicine
5.1.3 Restraints
5.1.3.1 Complications associated with NGS data storage
5.1.3.2 Lack of skilled professional
5.2 DRO – Impact Analysis
5.3 Key Stakeholders
6 TECHNOLOGY: MARKET SIZE & ANALYSIS
6.1 Overview
6.2 Reversible terminator sequencing
6.3 Ion semiconductor sequencing
6.4 Sequencing by ligation
6.5 Single molecule real-time (SMRT) sequencing
6.6 Nanopore sequencing
6.7 Others
7 PRODUCT: MARKET SIZE & ANALYSIS
7.1 Overview
7.2 Instruments
7.3 Consumables and reagents
7.4 Services
8 APPLICATIONS: MARKET SIZE & ANALYSIS
8.1 Overview
8.2 Diagnostics
8.3 Biomarker discovery
8.4 Drug discovery
8.5 Agriculture and animal research
8.6 Other application
9 END-USER: MARKET SIZE & ANALYSIS
9.1 Overview
9.2 Hospital and reference laboratories
9.3 Academic and research institutions
9.4 Biotech and pharma companies
9.5 Others
10 REGIONS: MARKET SIZE AND ANALYSIS
10.1 Overview
10.2 North America
10.3 Europe
10.4 Asia Pacific
10.5 Rest of the World
11 COMPETITIVE LANDSCAPE
11.1 Overview
12 VENDOR PROFILES
12.1 Illumina, Inc
12.1.1 Overview
12.1.2 Illumina, Inc.: Recent Developments
12.1.3 Business Units
12.1.4 Geographic Revenue
12.1.5 Business Focus
12.1.6 SWOT Analysis
12.1.7 Business Strategies
12.2 Thermo Fisher Scientific Inc
12.2.1 Overview
12.2.2 Thermo Fisher Scientific Inc.: Recent Developments
12.2.3 Business Units
12.2.4 Geographic Presence
12.2.5 Business Focus
12.2.6 SWOT Analysis
12.2.7 Business Strategies
12.3 Pacific Biosciences of California, Inc
12.3.1 Overview
12.3.2 Geographic Presence
12.3.3 Business Focus
12.3.4 SWOT Analysis
12.3.5 Business Strategies
12.4 Oxford Nanopore Technologies Ltd
12.4.1 Overview
12.4.2 Business Focus
12.4.3 SWOT Analysis
12.4.4 Business Strategies
12.5 Beijing Genomics Institute
12.5.1 Overview
12.5.2 Business Focus
12.5.3 SWOT Analysis
12.5.4 Business Strategies
13 COMPANIES TO WATCH FOR
13.1 DNASTAR, Inc.,
13.1.1 Overview
13.2 Agilent Technologies, Inc
13.2.1 Overview
13.3 Qiagen N.V
13.3.1 Overview
13.4 Eurofins Scientific
13.4.1 Overview
13.5 Biomatters Limited
13.5.1 Overview
13.6 F .Hoffmann-La Roche
13.6.1 Overview
Annexure
Acronyms
Table 1 GLOBAL NEXT-GENERATION SEQUENCING MARKET BY APPLICATION, 2017–2024 ($MILLION)
Table 2 GLOBAL NEXT-GENERATION SEQUENCING MARKET REVENUE BY REGIONS, 2017–2024 ($MILLION)
Table 3 OTHER PROMINENT VENDORS OF NEXT-GENERATION SEQUENCING MARKET
Table 4 ILLUMINA, INC.: OFFERINGS
Table 5 THERMO FISHER SCIENTIFIC INC.: PRODUCT OFFERINGS
Table 6 PACIFIC BIOSCIENCES OF CALIFORNIA, INC.: OFFERINGS
Table 7 PACIFIC BIOSCIENCES OF CALIFORNIA, INC: RECENT DEVELOPMENTS
Table 8 OXFORD NANOPORE TECHNOLOGIES LTD: OFFERINGS
Table 9 OXFORD NANOPORE TECHNOLOGIES LTD: RECENT DEVELOPMENTS
Table 10 BEIJING GENOMICS INSTITUTE: OFFERINGS
Table 11 BEIJING GENOMICS INSTITUTE: RECENT DEVELOPMENTS
Table 12 DNASTAR, INC.: SNAPSHOT
Table 13 DNASTAR, INC.: RECENT DEVELOPMENTS
Table 14 AGILENT TECHNOLOGIES, INC.: SNAPSHOT
Table 15 AGILENT TECHNOLOGIES, INC.: RECENT DEVELOPMENTS
Table 16 QIAGEN N.V.: SNAPSHOT
Table 17 QIAGEN N.V.: RECENT DEVELOPMENTS
Table 18 EUROFINS SCIENTIFIC: SNAPSHOT
Table 19 EUROFIN SCIENTIFIC: RECENT DEVELOPMENTS
Table 20 BIOMATTERS LIMITED: SNAPSHOT
Table 21 BIOMATTERS LTD: RECENT DEVELOPMENTS
Table 22 F .HOFFMANN-LA ROCHE: SNAPSHOT
Table 23 F .HOFFMANN-LA ROCHE: RECENT DEVELOPMENTS
LIST OF CHARTS
Chart 1 RESEARCH METHODOLOGY OF GLOBAL NEXT-GENERATION SEQUENCING MARKET
Chart 2 GLOBAL NEXT-GENERATION SEQUENCING MARKET REVENUE, 2017–2024 ($MILLION)
Chart 3 SEGMENTATION OF GLOBAL NEXT-GENERATION SEQUENCING MARKET
Chart 4 PEST ANALYSIS OF GLOBAL NEXT-GENERATION SEQUENCING MARKET
Chart 5 PORTER 5 FORCES ON GLOBAL NEXT-GENERATION SEQUENCING MARKET
Chart 6 DRO – IMPACT ANALYSIS OF GLOBAL NEXT-GENERATION SEQUENCING MARKET
Chart 7 KEY STAKEHOLDERS
Chart 8 GLOBAL NEXT-GENERATION SEQUENCING BY TECHNOLOGY SEGMENTATION, 2017 (%)
Chart 9 GLOBAL NEXT-GENERATION SEQUENCING BY PRODUCT SEGMENTATION, 2017 (%)
Chart 10 GLOBAL NEXT-GENERATION MARKET BY APPLICATION SEGMENTATION, 2017 (%)
Chart 11 GLOBAL NEXT-GENERATION MARKET BY APPLICATION SEGMENTATION, 2024 (%)
Chart 12 GLOBAL DIAGNOSTICS MARKET REVENUE FORECAST, 2017–2024 ($MILLION)
Chart 13 GLOBAL BIOMARKER DISCOVERY MARKET REVENUE FORECAST, 2017–2024 ($MILLION)
Chart 14 GLOBAL DRUG DISCOVERY MARKET REVENUE FORECAST, 2017–2024 ($MILLION)
Chart 15 GLOBAL AGRICULTURE AND ANIMAL RESEARCH MARKET REVENUE FORECAST, 2017–2024 ($MILLION)
Chart 16 GLOBAL OTHERS MARKET REVENUE FORECAST, 2017–2024 ($MILLION)
Chart 17 GLOBAL NEXT-GENERATION SEQUENCING BY END-USERS SEGMENTATION, 2017 (%)
Chart 18 GLOBAL NEXT-GENERATION SEQUENCING MARKET BY GEOGRAPHICAL SEGMENTATION, 2017 (%)
Chart 19 NEXT-GENERATION SEQUENCING MARKET REVENUE IN NORTH AMERICA, 2017–2024 ($MILLION)
Chart 20 NEXT-GENERATION SEQUENCING MARKET REVENUE IN EUROPE, 2017–2024 ($MILLION)
Chart 21 NEXT-GENERATION SEQUENCING MARKET REVENUE IN ASIA PACIFIC, 2017–2024 ($MILLION)
Chart 22 NEXT-GENERATION SEQUENCING MARKET REVENUE IN REST OF THE WORLD, 2017–2024 ($MILLION)
Chart 23 ILLUMINA, INC.: OVERVIEW SNAPSHOT
Chart 24 ILLUMINA, INC.: BUSINESS UNITS
Chart 25 ILLUMINA, INC.: GEOGRAPHIC REVENUE
Chart 26 ILLUMINA, INC.: SWOT ANALYSIS
Chart 27 THERMO FISHER SCIENTIFIC INC.: OVERVIEW SNAPSHOT
Chart 28 THERMO FISHER SCIENTIFIC INC.: BUSINESS UNITS REVENUE
Chart 29 THERMO FISHER SCIENTIFIC INC.: GEOGRAPHICAL PRESENCE
Chart 30 THERMO FISHER SCIENTIFIC INC.: SWOT ANALYSIS
Chart 31 PACIFIC BIOSIENCES OF CALIFORNIA, INC.: OVERVIEW SNAPSHOT
Chart 32 PACIFIC BIOSCIENCES OF CALIFORNIA, INC.: GEOGRAPHIC PRESENCE
Chart 33 PACIFIC BIOSCIENCES OF CALIFORNIA, INC.: SWOT ANALYSIS
Chart 34 OXFORD NANOPORE TECHNOLOGIES LTD: SWOT ANALYSIS
Chart 35 BEIJING GENOMICS INSTITUTE: SWOT ANALYSIS
Chart 1 RESEARCH METHODOLOGY OF GLOBAL NEXT-GENERATION SEQUENCING MARKET
Chart 2 GLOBAL NEXT-GENERATION SEQUENCING MARKET REVENUE, 2017–2024 ($MILLION)
Chart 3 SEGMENTATION OF GLOBAL NEXT-GENERATION SEQUENCING MARKET
Chart 4 PEST ANALYSIS OF GLOBAL NEXT-GENERATION SEQUENCING MARKET
Chart 5 PORTER 5 FORCES ON GLOBAL NEXT-GENERATION SEQUENCING MARKET
Chart 6 DRO – IMPACT ANALYSIS OF GLOBAL NEXT-GENERATION SEQUENCING MARKET
Chart 7 KEY STAKEHOLDERS
Chart 8 GLOBAL NEXT-GENERATION SEQUENCING BY TECHNOLOGY SEGMENTATION, 2017 (%)
Chart 9 GLOBAL NEXT-GENERATION SEQUENCING BY PRODUCT SEGMENTATION, 2017 (%)
Chart 10 GLOBAL NEXT-GENERATION MARKET BY APPLICATION SEGMENTATION, 2017 (%)
Chart 11 GLOBAL NEXT-GENERATION MARKET BY APPLICATION SEGMENTATION, 2024 (%)
Chart 12 GLOBAL DIAGNOSTICS MARKET REVENUE FORECAST, 2017–2024 ($MILLION)
Chart 13 GLOBAL BIOMARKER DISCOVERY MARKET REVENUE FORECAST, 2017–2024 ($MILLION)
Chart 14 GLOBAL DRUG DISCOVERY MARKET REVENUE FORECAST, 2017–2024 ($MILLION)
Chart 15 GLOBAL AGRICULTURE AND ANIMAL RESEARCH MARKET REVENUE FORECAST, 2017–2024 ($MILLION)
Chart 16 GLOBAL OTHERS MARKET REVENUE FORECAST, 2017–2024 ($MILLION)
Chart 17 GLOBAL NEXT-GENERATION SEQUENCING BY END-USERS SEGMENTATION, 2017 (%)
Chart 18 GLOBAL NEXT-GENERATION SEQUENCING MARKET BY GEOGRAPHICAL SEGMENTATION, 2017 (%)
Chart 19 NEXT-GENERATION SEQUENCING MARKET REVENUE IN NORTH AMERICA, 2017–2024 ($MILLION)
Chart 20 NEXT-GENERATION SEQUENCING MARKET REVENUE IN EUROPE, 2017–2024 ($MILLION)
Chart 21 NEXT-GENERATION SEQUENCING MARKET REVENUE IN ASIA PACIFIC, 2017–2024 ($MILLION)
Chart 22 NEXT-GENERATION SEQUENCING MARKET REVENUE IN REST OF THE WORLD, 2017–2024 ($MILLION)
Chart 23 ILLUMINA, INC.: OVERVIEW SNAPSHOT
Chart 24 ILLUMINA, INC.: BUSINESS UNITS
Chart 25 ILLUMINA, INC.: GEOGRAPHIC REVENUE
Chart 26 ILLUMINA, INC.: SWOT ANALYSIS
Chart 27 THERMO FISHER SCIENTIFIC INC.: OVERVIEW SNAPSHOT
Chart 28 THERMO FISHER SCIENTIFIC INC.: BUSINESS UNITS REVENUE
Chart 29 THERMO FISHER SCIENTIFIC INC.: GEOGRAPHICAL PRESENCE
Chart 30 THERMO FISHER SCIENTIFIC INC.: SWOT ANALYSIS
Chart 31 PACIFIC BIOSIENCES OF CALIFORNIA, INC.: OVERVIEW SNAPSHOT
Chart 32 PACIFIC BIOSCIENCES OF CALIFORNIA, INC.: GEOGRAPHIC PRESENCE
Chart 33 PACIFIC BIOSCIENCES OF CALIFORNIA, INC.: SWOT ANALYSIS
Chart 34 OXFORD NANOPORE TECHNOLOGIES LTD: SWOT ANALYSIS
Chart 35 BEIJING GENOMICS INSTITUTE: SWOT ANALYSIS
